Page 69 - Read Online

Griffiths et al. Neuroimmunol Neuroinflammation 2020;7:51-67 I http://dx.doi.org/10.20517/2347-8659.2019.21 Page 65

2. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, et al. Cortical demyelination and diffuse white matter injury in
multiple sclerosis. Brain 2005;128:2705-12.
3. Lucchinetti CF, Popescu BFG, Bunyan RF, Moll NM, Roemer SF, et al. Inflammatory cortical demyelination in early multiple sclerosis.
N Engl J Med 2011;365:2188-97.
4. Bevan RJ, Evans R, Griffiths L, Watkins LM, Rees MI, et al. Meningeal inflammation and cortical demyelination in acute multiple
sclerosis. Ann Neurol 2018;84:829-42.
5. Kutzelnigg A, Faber-Rod JC, Bauer J, Lucchinetti CF, Sorensen PS, et al. Widespread demyelination in the cerebellar cortex in multiple
sclerosis. Brain Pathol 2007;17:38-44.
6. Calabrese M, Magliozzi R, Ciccarelli O, Geurts JJ, Reynolds R, et al. Exploring the origins of grey matter damage in multiple sclerosis.
Nat Rev Neurosci 2015;16:147-58.
7. Calabrese M, Romualdi C, Poretto V, Favaretto A, Morra A, et al. The changing clinical course of multiple sclerosis: a matter of gray
matter. Ann Neurol 2013;74:76-83.
8. Dalton CM, Chard DT, Davies GR, Miszkiel KA, Altmann DR, et al. Early development of multiple sclerosis is associated with
progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004;127:1101-7.
9. Calabrese M, Rinaldi F, Mattisi I, Bernardi V, Favaretto A, et al. The predictive value of gray matter atrophy in clinically isolated
syndromes. Neurology 2011;77:257-63.
10. Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, et al. Gray matter atrophy is related to long-term disability in multiple
sclerosis. Ann Neurol 2008;64:247-54.
11. Scalfari A, Romualdi C, Nicholas RS, Mattoscio M, Magliozzi R, et al. The cortical damage, early relapses, and onset of the progressive
phase in multiple sclerosis. Neurology 2018;90:e2107-18.
12. Vercellino M, Plano F, Votta B, Mutani R, Giordana MT, et al. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol
2005;64:1101-7.
13. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis
associate with early onset of disease and severe cortical pathology. Brain 2007;130:1089-104.
14. Pitzalis C, Jones GW, Bombardieri M, Jones SA. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat Rev
Immunol 2014;14:447-62.
15. Bø L, Vedeler C, Nyland H, rapp BD, Mørk SJ. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte
infiltration. Mult Scler 2003;9:323-31.
16. Magliozzi R, Howell OW, Reeves C, Roncaroli F, Nicholas R, et al. A Gradient of neuronal loss and meningeal inflammation in multiple
sclerosis. Ann Neurol 2010;68:477-93.
17. Lassmann H. Pathogenic mechanisms associated with different clinical courses of multiple sclerosis. Front Immunol 2019;10:1-14.
18. Howell OW, Reeves CA, Nicholas R, Carassiti D, Radotra B, et al. Meningeal inflammation is widespread and linked to cortical
pathology in multiple sclerosis. Brain 2011;134:2755-71.
19. Haider L, Zrzavy T, Hametner S, Höftberger R, Bagnato F, et al. The topograpy of demyelination and neurodegeneration in the multiple
sclerosis brain. Brain 2016;139:807-15.
20. Bø L, Vedeler C a, Nyland HI, Trapp BD, Mørk SJ. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J
Neuropathol Exp Neurol 2003;62:723-32.
21. Lassmann H, Raine CS, Antel J, Prineas JW. Immunopathology of multiple sclerosis: report on an international meeting held at the
Institute of Neurology of the University of Vienna. J Neuroimmunol 1998;86:213-7.
22. Mai JK, George Paxinos TV. Atlas of the Human Brain. 3rd edition. Academic Press; 2007.
23. Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of
patients with secondary progressive multiple sclerosis. Brain Pathol 2004;14:164-74.
24. Motulsky HJ. ‘When to choose a nonparametric test’. GraphPad Stat. Guid. Available from: https://www.graphpad.com/guides/prism/8/
statistics/index.htm [Last accessed on 2 Mar 2020]
25. Carassiti D, Altmann DR, Petrova N, Pakkenberg B, Scaravilli F, et al. Neuronal loss, demyelination and volume change in the multiple
sclerosis neocortex. Neuropathol Appl Neurobiol 2018;44:377-90.
26. Trapp BD, Vignos M, Dudman J, Chang A, Fisher E, et al. Cortical neuronal densities and cerebral white matter demyelination in multiple
sclerosis: a retrospective study. Lancet Neurol 2018;17:870-84.
27. Moll NM, Rietsch AM, Ransohoff AJ, Cossoy MB, Huang D, et al. Cortical demyelination in PML and MS: similarities and differences.
Neurology 2008;70:336-43.
28. Cifelli A, Arridge M, Jezzard P, Esiri MM, Palace J, et al. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002;52:650-3.
29. Fadda G, Brown RA, Magliozzi R, Aubert-Broche B, O’Mahony J, et al. A surface-in gradient of thalamic damage evolves in pediatric
multiple sclerosis. Ann Neurol 2019;85:340-51.
30. Liu Z, Pardini M, Yaldizli O, Sethi V, Muhlert N, et al. Magnetization transfer ratio measures in normal-appearing white matter show
periventricular gradient abnormalities in multiple sclerosis. Brain 2015;138:1239-46.
31. Kearney H, Yiannakas MC, Samson RS, Wheeler-Kingshott CA, Ciccarelli O, et al. Investigation of magnetization transfer ratio-derived
pial and subpial abnormalities in the multiple sclerosis spinal cord. Brain 2014;137:2456-68.
32. Samson RS, Cardoso MJ, Muhlert N, Sethi V, Wheeler-Kingshott CA, et al. Investigation of outer cortical magnetisation transfer ratio
abnormalities in multiple sclerosis clinical subgroups. Mult Scler 2014;20:1322-30.
33. Mainero C, Louapre C, Govindarajan ST, Giannì C, Nielsen AS, et al. A gradient in cortical pathology in multiple sclerosis by in vivo